ICR in the evaluation of all medicine and health research in Norway by the Research Council
All medicine and health research in Norway has been evaluated by Norges forskningsråd in 2023-24 (aggregated report published April 8, 2025, link below). At the Institute for Cancer Research (ICR), Oslo University Hospital and Det medisinske fakultet UiO, our six research departments in ICR with >370 employees in 26 research groups, 29 project groups and seven core facility units were evaluated separately as six units (Cancer Genetics, Cancer Immunology, Molecular Cell Biology, Molecular Oncology, Radiation Biology, Tumor Biology). As Head of the ICR, I am very proud to say that our large and professional research organisation was evaluated as internationally excellent to outstanding on research quality, very strong to outstanding on organisation and with considerable to extensive societal impact!
We were also part of the evaluation of the Division of Cancer Medicine at the admin unit level, and we contributed strongly to four of the five "Impact Cases" the Division submitted (on CoEs and basic cancer research, immune-oncology and cell therapy, precision cancer medicine, and the comprehensive cancer centre concept). I am happy to say that the Division scored excellently and that the Impact Cases were characterised as “strong, demonstrating the ambitions and abilities to deliver and implement ambitious research achievements.”
Kjetil Taskén, Head of ICR
Aggregated report:
